KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifeward (LFWD) Research & Development (2016 - 2025)

Lifeward (LFWD) has disclosed Research & Development for 11 consecutive years, with $843000.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 25.46% to $843000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, down 29.75% year-over-year, with the annual reading at $3.2 million for FY2025, 29.75% down from the prior year.
  • Research & Development hit $843000.0 in Q4 2025 for Lifeward, up from $721000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.3 million in Q4 2023 to a low of $638000.0 in Q3 2021.
  • Historically, Research & Development has averaged $949600.0 across 5 years, with a median of $912500.0 in 2022.
  • Biggest five-year swings in Research & Development: soared 71.68% in 2024 and later tumbled 36.35% in 2025.
  • Year by year, Research & Development stood at $696000.0 in 2021, then skyrocketed by 58.48% to $1.1 million in 2022, then rose by 19.49% to $1.3 million in 2023, then fell by 14.19% to $1.1 million in 2024, then fell by 25.46% to $843000.0 in 2025.
  • Business Quant data shows Research & Development for LFWD at $843000.0 in Q4 2025, $721000.0 in Q3 2025, and $767000.0 in Q2 2025.